Lunate Holding RSC Ltd
Lunate Holding RSC Ltd reported 4 US-listed holdings worth $210.9 million in its 13F for the quarter ended 31 December 2024, filed 14 February 2025. Its largest: Revolution Medicines, Inc. (45.5%), Birkenstock Holding plc (27.1%) and Lineage Inc. (16.7%).
From the quarter ended 30 June 2026, its holdings are reported in Lunate Capital Ltd's 13F; this page shows its own last report.
Reported holdings$210.9M
Positions4
The largest ten100.0%of its reported holdings
Latest 13FQ4 2024filed 14 February 2025
The 4 largest of its 4 positions, each sized by its share of the reported holdings.
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Revolution Medicines, Inc. RVMD | 2.2M | $96.1 million | 45.54% | |
| Birkenstock Holding plc BIRK | 1.0M | $57.2 million | 27.13% | |
| Lineage Inc. LINE | 600.0K | $35.1 million | 16.66% | |
| Neumora Therapeutics Inc. NMRA | 2.1M | $22.5 million | 10.67% |
Every US-listed position in the fund's 13F for the quarter ended 31 December 2024, by the value it reported.